Última hora
DEUS-Senator Lindsey Graham stirbt mit 71 JahrenTRBavi Tayfunu Çin'de Alarm Durumuna Yol Açtı, Okullar Tatil EdildiRUСемья Усольцевых не найдена в Красноярском крае после четырехдневных поисковTRUzmanlar: İngiltere'de Sıcak Hava Dalgası 2.700'den Fazla Can Almış OlabilirRUМишустин: На восстановление Курской, Белгородской и Брянской областей выделено 10 млрд рублейKRPresident Lee Proposes Future Response Fund Using Extra Tax RevenueTRMigros, ChatGPT'ye Entegre Olan İlk Gıda Perakendecisi OlduCN中國外交部強烈譴責日本外長涉南海言論ITBiglietti semifinale Francia-Spagna a Dallas: prezzi crollano del 60% dopo eliminazione USADEBerliner SPD-Spitzenkandidat Krach schließt Zusammenarbeit mit CDU-Kandidat Evers nicht ausDEUS-Senator Lindsey Graham stirbt mit 71 JahrenTRBavi Tayfunu Çin'de Alarm Durumuna Yol Açtı, Okullar Tatil EdildiRUСемья Усольцевых не найдена в Красноярском крае после четырехдневных поисковTRUzmanlar: İngiltere'de Sıcak Hava Dalgası 2.700'den Fazla Can Almış OlabilirRUМишустин: На восстановление Курской, Белгородской и Брянской областей выделено 10 млрд рублейKRPresident Lee Proposes Future Response Fund Using Extra Tax RevenueTRMigros, ChatGPT'ye Entegre Olan İlk Gıda Perakendecisi OlduCN中國外交部強烈譴責日本外長涉南海言論ITBiglietti semifinale Francia-Spagna a Dallas: prezzi crollano del 60% dopo eliminazione USADEBerliner SPD-Spitzenkandidat Krach schließt Zusammenarbeit mit CDU-Kandidat Evers nicht aus
Newsgather
BackIndia's Slow Adoption of Affordable GLP-1 Weight-Loss Drugs Raises Questions
India's Slow Adoption of Affordable GLP-1 Weight-Loss Drugs Raises Questions
Salud
Economic Times27.06.2026SaludIndia

India's Slow Adoption of Affordable GLP-1 Weight-Loss Drugs Raises Questions

En resumen

Nithin Kamath questions India's slow uptake of affordable GLP-1 weight-loss drugs despite rising obesity, citing challenges like long-term adherence and physician conservatism, prompting a cautionary response from Kiran Mazumdar-Shaw emphasizing diet and exercise for non-diabetic, non-obese individuals.

Resumen generado por IA

Tamaño de fuente

Nithin Kamath questions India's slow uptake of affordable GLP-1 weight-loss drugs despite rising obesity, citing challenges like long-term adherence and physician conservatism, prompting a cautionary response from Kiran Mazumdar-Shaw emphasizing diet and exercise for non-diabetic, non-obese individuals.

Read the full article on Economic Times

Temas relacionados

This article was originally published by Economic Times.

Noticias relacionadas

Más sobre este temaGLP-1 drugs